Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
S2 Episode 6: Is MDMA a Potential Treatment for Negative Symptoms of Schizophrenia? Exploring Stigma and Strategies to Alleviate Symptoms
|
Jul 20, 2023 |
|
S2 Episode 5: First-Episode Schizophrenia: The Importance of Engaging and Educating Patients and Their Families in Treatment
|
Jun 21, 2023 |
|
S2 Episode 4: Common and Commonly Unrecognized: Clinical High-risk Syndrome, Psychosis, and Schizophrenia
|
May 23, 2023 |
|
S2 Episode 3: Psychiatric Comorbidity in Schizophrenia: Assessing Patients and the Impact on Treatment Decisions and Outcomes
|
Apr 19, 2023 |
|
S2 Episode 2: Long-Acting Injectables and Schizophrenia: Mitigating the Risk for Relapse and Rehospitalization
|
Mar 22, 2023 |
|
S2 Episode 1: Treatment-Resistant Schizophrenia: Detection, Management, and the Importance of Early Initiation of Treatment
|
Mar 22, 2023 |
|
S1 Episode 6: Relapse in Schizophrenia: Why It Occurs, How Often It Occurs, and What We Can Do About It
|
Dec 07, 2022 |
|
S1 Episode 5: Neuroimaging in Schizophrenia: What Have We Learned?
|
Nov 09, 2022 |
|
S1 Episode 4: How Can We Assess Cognitive Functioning in Patients With Schizophrenia? And What Can We Do About It?
|
Oct 05, 2022 |
|
S1 Episode 3: What New Antipsychotic Drugs Are Available for Schizophrenia? What Drugs Are Under Development? And What Do They Potentially Offer?
|
Sep 13, 2022 |
|
S1 Episode 2: Antipsychotics in Schizophrenia: Effectiveness and Optimal Dosing
|
Aug 02, 2022 |
|
S1 Episode 1: What Are the Major Metabolic and Neurologic Risks Associated With Antipsychotic Medications?
|
Aug 02, 2022 |